Eccogene

Eccogene focuses on the research and development of small molecule drugs for metabolic diseases, committed to innovatively addressing unmet clinical needs through insights into metabolism and immunity, and providing high-quality, affordable drugs for the majority of patients in the future. Engaged in early-stage new drug research, it ultimately aims to carry out patent licensing, patent transfer, co-development, and drug sales.